STAT-3 Inhibitors: State of the Art and New Horizons for Cancer Treatment

E-ISSN： 1875-533x|18|16|2359-2375

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.16, 2011-06, pp. : 2359-2375

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small Molecule Inhibitors of STAT3 for Cancer Therapy

Current Medicinal Chemistry, Vol. 18, Iss. 26, 2011-09 ,pp. : 4012-4018

Bentham Science Publishers

Access to resources Recommend Favorite

Medical treatment of small cell lung cancer: state of the art and new development

By Sgambato Assunta Casaluce Francesca Maione Paolo Rossi Antonio Sacco Paola Claudia Panzone Filomena Ciardiello Fortunato Gridelli Cesare

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 15, 2013-10 ,pp. : 2019-2031

Informa Healthcare

Access to resources Recommend Favorite

Current State of the Art of New Tubulin Inhibitors in the Clinic

Current Clinical Pharmacology, Vol. 1, Iss. 1, 2006-01 ,pp. : 57-70

Bentham Science Publishers

Access to resources Recommend Favorite

Photodynamic Therapy in the Treatment of Cancer: Current State of the Art

By Hsi R.A. Rosenthal D.I. Glatstein E.

Drugs, Vol. 57, Iss. 5, 1999-05 ,pp. : 725-734

Adis International

Access to resources Recommend Favorite

New Approaches to Target the Androgen Receptor and STAT3 for Prostate Cancer Treatments

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 3, 2009-03 ,pp. : 395-400

Bentham Science Publishers

Access to resources Recommend Favorite